Veterinary Molecular Diagnostics Market

Market Overview:

The global veterinary molecular diagnostics market size reached US$ 690.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,391.9 Million by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032. The growing adoption of pets among the masses, increasing advancements in molecular diagnostic technologies, and rising implementation of stringent regulatory guidelines and quality control standards to standardize molecular diagnostic tests in veterinary practice are some of the major factors propelling the market.

Veterinary molecular diagnostics refers to the application of molecular biology techniques to identify and analyze genetic material, proteins, and other molecular markers in animals. It involves the examination of deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and proteins to detect pathogens, genetic mutations, and disease markers in animals. It enables the early detection of diseases, reducing the severity and spread of infections among animals. It allows for personalized treatment plans based on the genetic profile of an animal, leading to more effective therapies and better outcomes. It contributes to scientific knowledge, aiding in the development of vaccines, treatments, and a deeper understanding of animal biology.

At present, the increasing demand for molecular diagnostics that can rapidly and accurately detect infectious agents in animals, helping to prevent disease transmission to humans and safeguard public health is impelling the growth of the market. Besides this, the rising utilization of personalized medicine in veterinary care to tailor treatment plans and predict disease susceptibility is contributing to the growth of the market. In addition, the growing advancements in biotechnology and genomics, enabling the development of innovative molecular diagnostic techniques, are offering a favorable market outlook. Apart from this, the increasing expansion of veterinary research and development (R&D) activities is supporting the growth of the market. Additionally, the rising implementation of stringent regulatory guidelines and quality control standards to standardize molecular diagnostic tests in veterinary practice is bolstering the growth of the market.

Veterinary Molecular Diagnostics Market Trends/Drivers:

Growing adoption of pets among the masses

The growing adoption of pets among the masses is currently exerting a positive influence on the expansion of the veterinary molecular diagnostics market. This surge in pet ownership is resulting in a higher demand for veterinary services, including diagnostics. As a result, the veterinary molecular diagnostics market is experiencing continuous growth in response to the current and ongoing pet adoption trend. Besides this, advancements in veterinary molecular diagnostics technology are actively contributing to the market growth. The development of more accurate, efficient, and rapid diagnostic tests is facilitating early disease detection and improving the overall healthcare of pets. This technological progress is presently enhancing the capabilities of veterinary clinics and laboratories, thus positively impacting the veterinary molecular diagnostics market.

Rising prevalence of animal diseases

At present, the rising prevalence of animal diseases is propelling the growth of the veterinary molecular diagnostics market. Besides this, the continuous emergence and spread of infectious diseases among animals is increasing the demand for accurate and rapid diagnostic solutions. Veterinary molecular diagnostics, with their ability to detect and identify pathogens at the genetic level, offer precise and timely diagnosis. This enables veterinarians and animal health professionals to initiate appropriate treatment measures promptly, reducing the severity of outbreaks and minimizing economic losses in the livestock and pet industries. Furthermore, the rising awareness among pet owners and livestock producers about the importance of early disease detection and prevention is leading to a higher demand for veterinary molecular diagnostic services. This growing awareness is translating into a higher willingness to invest in advanced diagnostic procedures, boosting the overall demand.

Increasing advancements in molecular diagnostic technologies

Presently, the increasing advancements in molecular diagnostic technologies are bolstering the growth of the market. Cutting-edge molecular diagnostic technologies, such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and microarray analysis, are continually evolving to provide veterinarians with unparalleled insights into the health of animals. This ongoing evolution ensures that veterinary professionals can detect and diagnose a broader spectrum of diseases and conditions in animals with greater sensitivity and specificity. Furthermore, the integration of automation and robotics into molecular diagnostic processes is streamlining workflow and reducing the margin of error. These advancements are enhancing the efficiency of veterinary laboratories and enabling quicker turnaround times for test results. As a result, veterinarians can make timelier and more informed decisions regarding animal health management.

Veterinary Molecular Diagnostics Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, technology, animal type, disease type, and end user.

Breakup by Product:

• Kits and Reagents
• Instruments
• Software and Services
   

Kits and reagents dominate the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes kits and reagents, instruments, and software and services. According to the report, kits and reagents represented the largest segment.

In veterinary molecular diagnostics, various kits and reagents are essential for conducting tests and experiments to detect, identify, and analyze nucleic acids (DNA and RNA) from animal samples. These molecular diagnostic tools are used for a wide range of purposes, including disease detection, genotyping, pathogen identification, and genetic research in animals. Kits and reagents for next-generation sequencing (NGS) are used to characterize the genomes of pathogens, aiding in the study of their evolution, drug resistance, and virulence factors. They also enable the study of epigenetic modifications in animal DNA, providing insights into gene regulation and potential links between epigenetic changes and disease susceptibility. They are used to screen for genetic mutations associated with hereditary diseases in animals. Breeders and veterinarians use this information for selective breeding and counseling owners about potential health risks in specific breeds.

Breakup by Technology:

• Real Time PCR
• Microarray
• DNA Sequencing
   

Real time PCR holds the largest share in the market

A detailed breakup and analysis of the market based on the technology has also been provided in the report. This includes real time PCR, microarray, and DNA sequencing. According to the report, real time PCR accounted for the largest market share.

Real-time polymerase chain reaction (real-time PCR), also known as quantitative PCR (qPCR), is a molecular biology technique used to amplify and quantify specific DNA sequences in real time. It is a sensitive and accurate method for measuring the amount of a target DNA or RNA molecule in a biological sample. Real-time PCR is widely employed to examine and quantify pathogens in animals, including viruses, bacteria, fungi, and parasites. It enables vets to diagnose diseases, such as canine parvovirus, feline leukemia virus, bovine respiratory syncytial virus, and avian influenza virus. It also allows for early and accurate diagnosis, enabling prompt treatment and disease management.

Breakup by Animal Type:

• Companion Animal
• Livestock Animal
   

Companion animal holds the biggest share in the market

A detailed breakup and analysis of the market based on the animal type have also been provided in the report. This includes companion animal and livestock animal. According to the report, companion animal accounted for the largest market share.

Companion animals like dogs, cats, and other pets, require veterinary molecular diagnostics to detect diseases and health conditions. Some companion animals are prone to genetic disorders or inherited diseases. Molecular diagnostics can identify genetic mutations or markers associated with these conditions, allowing breeders to make informed decisions about breeding and helping veterinarians manage the health of affected animals. Molecular tests can rapidly identify the presence of infectious agents, including viruses, bacteria, and parasites. This is crucial for diagnosing and managing diseases like parvovirus, feline leukemia, and Lyme disease. Molecular diagnostics also play a vital role in advancing veterinary medicine and contributing to animal health.

Breakup by Disease Type:

• Vector-borne Diseases
• Respiratory Pathogens
• Diarrhea Pathogens
• Others
   

Vector-borne diseases hold the maximum share in the market

A detailed breakup and analysis of the market based on the disease type have also been provided in the report. This includes vector-borne diseases, respiratory pathogens, diarrhea pathogens, and others. According to the report, vector-borne diseases accounted for the largest market share.

Vector-borne diseases in animals are infections that are transmitted from one animal to another through the bites of arthropod vectors, similar to how these diseases are transmitted to humans. They can have significant economic impacts on agriculture and can reduce the productivity of livestock, decrease meat and milk production, and even lead to animal deaths. Molecular diagnostic techniques, including PCR, can rapidly and accurately detect the genetic material of the pathogens responsible for vector-borne diseases in animals. This early and precise diagnosis is essential for effective disease management. These techniques can be used to monitor the progression of disease in infected animals and help veterinarians assess the severity of the infection and adjust treatment plans accordingly.

Breakup by End User:

• Veterinary Hospitals
• Clinical Laboratories
• Research Institutes
   

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes veterinary hospitals, clinical laboratories, and research institutes.

Veterinary molecular diagnostics plays a crucial role in veterinary hospitals by offering advanced tools and techniques for the monitoring and treatment of diseases in animals. They can be used in biosecurity protocols to quickly identify and isolate infected animals, preventing the spread of contagious diseases within veterinary hospitals and breeding facilities.

Veterinary molecular diagnostics plays a pivotal role in clinical laboratories dedicated to animal healthcare. These sophisticated techniques harness the power of molecular biology to provide rapid, precise, and comprehensive insights into the health of animals. Furthermore, clinical laboratories utilize genetic testing to screen for inherited diseases, enabling breeders and pet owners to make informed decisions regarding breeding practices and ensuring the well-being of companion and livestock animals.

Veterinary molecular diagnostics plays an indispensable role in research institutes dedicated to advancing the knowledg of animal health, genetics, and disease mechanisms. These institutes leverage cutting-edge molecular techniques, such as Polymerase Chain Reaction (PCR), DNA sequencing, and genotyping, to conduct a wide array of studies that benefit both animals and humans.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

North America exhibits a clear dominance, accounting for the largest veterinary molecular diagnostics market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the rising adoption of pets among the masses to enjoy their companionship. Besides this, the increasing affordability of molecular diagnostic tests, making them a viable option for a wider range of veterinary practices, is contributing to the growth of the market. Apart from this, the rising emergence of new and re-emergence of existing diseases in animals is supporting the growth of the market. Additionally, the increasing awareness about the beneficial aspects of molecular diagnostics in helping veterinarians respond promptly to disease outbreaks is strengthening the growth of the market.

Asia pacific is estimated to expand further in this domain due to the rising awareness among pet owners and vets about the importance of early disease detection for animals. Moreover, the increasing investments in animal healthcare facilities by pet owners are bolstering the growth of the market.

Competitive Landscape:

Key market players are developing innovative and more accurate diagnostic tests for animals by creating new assays, improving the sensitivity and specificity of existing tests, and expanding their test menu to cover a broader range of diseases. They are also expanding their product portfolios to include a wider range of diagnostic tests for different animal species, including companion animals (dogs and cats), livestock (cattle, pigs, and poultry), and exotic animals. Top companies are establishing partnerships or collaborations with distributors and veterinary clinics in different regions to reach a global customer base. They are also incorporating automation and advanced technologies into their diagnostic platforms to streamline testing processes, reduce turnaround times, and enhance the accuracy of results.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

• Biochek B.V.
• bioMérieux SA
• HealthGene Corporation
• Heska Corporation
• IDEXX Laboratories Inc.
• INDICAL BIOSCIENCE GmbH
• Ingenetix GmbH
• NEOGEN Corporation
• Qiagen N.V
• Thermo Fisher Scientific Inc.
• Veterinary Molecular Diagnostics Inc.
• Zoetis Inc.
   

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

• In 2021, Biochek B.V. announced the opening of its new affiliate in South Africa, which will be the first new affiliate of the BioChek Group presenting integrated range of products.
• In June 2023, IDEXX Laboratories Inc. announced the launch of the first veterinary diagnostic test for detecting kidney complications in cats and dogs.
• In August 2023, NEOGEN Corporation announced the release of an extensive selection of new genetic tests through Paw Print Genetics® and Canine HealthCheck® solutions, which can identify genetic sequences associated with potential diseases and other trait.

Veterinary Molecular Diagnostics Market Report Scope:

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the veterinary molecular diagnostics market from 2018-2032.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the global veterinary molecular diagnostics market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the veterinary molecular diagnostics industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.